Circulating miRNA-125b Is a Potential Biomarker Predicting Response to Rituximab in Rheumatoid Arthritis

Although biologic therapies have changed the course of rheumatoid arthritis (RA), today's major challenge remains to identify biomarkers to target treatments to selected patient groups. Circulating micro(mi)RNAs represent a novel class of molecular biomarkers whose expression is altered in RA....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Duroux-Richard, Isabelle, Pers, Yves-Marie, Fabre, Sylvie, Ammari, Meryem, Baeten, Dominique, Cartron, Guillaume, Touitou, Isabelle, Jorgensen, Christian, Apparailly, Florence
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3980876/
https://ncbi.nlm.nih.gov/pubmed/24778468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/342524
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars